Products

Alfarabilab

نكتشف الداء لينفع الدواء.

alfarabilab.com Industry Software / Healthcare & Care Providers

AI Benchmark
Desktop
Mobile
Monthly visits
61.1K
Down5.9%MoMOct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
One-time
No monthly subscription pricing
Creators
Unlinked
No verified creators
Launched
3y ago
2023-09-18 · Est.

Traffic

Monthly visitsData through Oct 2026
Events1 change

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    Sep 18, 2023 · 3y agoWebsite

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Organic Search53%
  • Direct27%
  • Paid Search14%
  • Other5%

Countries

  • Saudi Arabia92%
  • Egypt8%

Search

Domain authority —Domain registered 2023-09-18

KeywordMonthly volume
nipt21.3K
مختبرات الفارابي710
الفارابي مختبر270
مختبرات الفارابي الطبية90
اختبار حمل مختبرات الفارابي90

Traffic data: Vaneform

Pricing

باقة المسبح
96 ر.س غير شامل ضريبة القيمة المضافة
6 تحاليل · بدون صيام

Trial: None · Observed 2026-11-15 · Pricing page

Pages & changes

Tracked since 2026-11-04

Key pages

Weekly snapshots
www.alfarabilab.com/ar Snapshot 2026-11-17

Changes

  1. Nov 11 · 6d ago

    Added product format: WebFeatures

    —→web

    At the time: 61.1K visits/mo

Questions & evidence

How much does Alfarabilab cost?
باقة المسبح: 96 ر.س غير شامل ضريبة القيمة المضافة. Observed 2026-11-15. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Alfarabilab get?
Vaneform estimates 61.1K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Alfarabilab and what platforms does it support?
Alfarabilab is catalogued under Healthcare & Care Providers: نكتشف الداء لينفع الدواء. Supported platforms: Web.

Related products in this category

Industry Software / Healthcare & Care Providers

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.